Page 20 - Tyra Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tyra biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tyra Biosciences Inc Today - Breaking & Trending Today

Tyra Biosciences to Participate in Upcoming Investor Conferences

/PRNewswire/ Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that. ....

United States , Tyra Biosciences , Todd Harris , Tyra Biosciences Inc , Fibroblast Growth Factor Receptor , Oncology Virtual Symposium ,

Tyra Biosciences to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., March 29, 2023 /PRNewswire/ Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Rec. ....

United States , Todd Harris , Amy Conrad , Tyra Biosciences , Tyra Biosciences Inc , Fibroblast Growth Factor Receptor , Oncology Virtual Symposium ,

HC Wainwright Reaffirms "Buy" Rating for Tyra Biosciences (NASDAQ:TYRA)

HC Wainwright reiterated their buy rating on shares of Tyra Biosciences (NASDAQ:TYRA – Get Rating) in a report published on Thursday, Benzinga reports. The brokerage currently has a $17.00 price target on the stock. HC Wainwright also issued estimates for Tyra Biosciences’ Q1 2024 earnings at ($0.40) EPS, Q2 2024 earnings at ($0.44) EPS, Q3 […] ....

United States , Daniel Bensen , Tyra Bioscience , Tyra Biosciences , Charles Schwab Investment Management Inc , America Corp , Geode Capital Management , Barclays Plc , Tyra Biosciences Inc , Mva Investors Llc , Get Rating , Mva Investors , Schwab Investment Management , Capital Management , Tyra Biosciences Daily , Nasdaq Tyra , Reiterated Rating , Hc Wainwright ,

Tyra Biosciences, Inc. (NASDAQ:TYRA) COO Sells $60,800.00 in Stock

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) COO Daniel Bensen sold 3,800 shares of the company’s stock in a transaction that occurred on Wednesday, March 22nd. The stock was sold at an average price of $16.00, for a total transaction of $60,800.00. Following the completion of the transaction, the chief operating officer now owns 527,981 […] ....

United States , Tyra Biosciences , Daniel Bensen , Fishman Jaya Ltd , America Corp , York Mellon Corp , Tyra Biosciences Inc , Tyra Biosciences Company Profile , Get Rating , New York Mellon Corp , Tyra Biosciences Daily , Nasdaq Tyra , Insider Trading , Nsider Trades ,

Insider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) COO Sells 3,800 Shares of Stock

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) COO Daniel Bensen sold 3,800 shares of Tyra Biosciences stock in a transaction dated Wednesday, March 22nd. The shares were sold at an average price of $16.00, for a total value of $60,800.00. Following the sale, the chief operating officer now owns 527,981 shares of the company’s stock, […] ....

United States , Tyra Biosciences , Daniel Bensen , Tyra Biosciences Inc , Jpmorgan Chase Co , Crossover Management , America Corp , Get Rating , Street Corp , Woodline Partners , Tyra Biosciences Daily , Nasdaq Tyra , Insider Trading , Nsider Trades ,